Sign up to save your podcasts
Or
Share 60 second reveal: 3 Regulatory authorities that can make or break your pharma or device sale
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
60 second reveal: 3 Regulatory authorities that can make or break your pharma or device sale
Darshan Kulkarni emphasizes that companies considering #acquisitions must be ready for scrutiny from multiple agencies: FDA, FTC, DOJ, and OIG. FDA examines various aspects like manufacturing, clinical research, pharmacovigilance, advertising, and distribution. FTC now addresses advertising and antitrust concerns. DOJ concentrates on corporate compliance. Is your organization well-prepared for these assessments? Get in touch with us for more information.
Support the show
www.kulkarnilawfirm.com
View all episodes
By Darshan Kulkarni
4.3
66 ratings
Darshan Kulkarni emphasizes that companies considering #acquisitions must be ready for scrutiny from multiple agencies: FDA, FTC, DOJ, and OIG. FDA examines various aspects like manufacturing, clinical research, pharmacovigilance, advertising, and distribution. FTC now addresses advertising and antitrust concerns. DOJ concentrates on corporate compliance. Is your organization well-prepared for these assessments? Get in touch with us for more information.
Support the show
www.kulkarnilawfirm.com